BriefCase vs Rapid SDH

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

BriefCase

by Aidoc Medical

Rapid SDH

by RapidAI (formerly iSchemaView)

AI Verdict

These tools are adjacent, as Rapid SDH is an AI module specifically for detecting subdural hematomas, while BriefCase is a communication and collaboration solution for sharing various critical medical imaging findings. Rapid SDH focuses on the rapid detection of a specific condition, whereas BriefCase streamlines the workflow for communicating any critical finding identified by an underlying AI platform.

Choose BriefCase if…

Choose BriefCase if your institution requires a comprehensive, AI-powered communication and collaboration solution to manage the entire workflow of critical medical imaging findings across multiple care teams. This tool is ideal for streamlining information sharing, automating follow-up, and ensuring auditable communication for a wide range of critical findings identified by the Aidoc platform.

View BriefCase →

Choose Rapid SDH if…

Choose Rapid SDH if your primary focus is the ultra-rapid and highly accurate AI-driven detection of suspected acute and chronic subdural hematomas on CT scans. This module is specifically designed for emergency and neurocritical care settings where immediate alerts are critical for accelerating time-sensitive diagnostic and treatment decisions for this specific neurological condition.

View Rapid SDH →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	BriefCase	Rapid SDH
Pricing	Enterprise	Contact vendor
Deployment	Cloud	Cloud-based, On-premise
BAA Available	Yes AI-estimated	Yes AI-estimated
FDA Status	Cleared AI-estimated	Yes AI-estimated
HIPAA	Yes AI-estimated	Yes AI-estimated

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	BriefCase	Rapid SDH
Name	BriefCase	Rapid SDH
Company	Aidoc Medical	RapidAI (formerly iSchemaView)
Description	Aidoc's BriefCase is an FDA-cleared AI-powered communication and collaboration solution integrated into the Aidoc platform, designed to streamline the sharing of critical medical imaging findings among care teams.	Rapid SDH by RapidAI is an FDA-cleared AI module that rapidly detects suspected acute and chronic subdural hematomas on CT scans, delivering notifications in under a minute to accelerate neurocritical care decisions.
Key Features	AI-driven critical finding detection (via Aidoc platform), Secure, real-time communication of findings, Customizable communication protocols, Automated follow-up tracking and reminders, Seamless integration with PACS, RIS, and EHR systems, Comprehensive audit trails for all communications, Prioritization of urgent cases for immediate attention, Mobile access for care team collaboration	AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH), Notifications to clinicians in one minute or less, High positive predictive value (PPV) of 99% (93% sensitivity, 99% specificity) for SDHs >1ml, Integration with Rapid mobile app, PACS, and email for notifications, Part of a comprehensive hemorrhagic and trauma care AI solution (with Rapid ICH and Rapid Hyperdensity), Analyzes non-contrast CT scans, Aids in streamlining decision-making and expediting patient care, Supports identification of treatment eligibility
Target Size	Large hospitals and health systems	Not specified
Specialties	Cardiology, Emergency Medicine, Neurology, Pulmonology, Radiology	Emergency Medicine, Neurosurgery, Radiology
Mobile App	both	Not specified

Videos

Demos, reviews, and walkthroughs featuring BriefCase and Rapid SDH.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What is the primary functional difference between Aidoc's BriefCase and RapidAI's Rapid SDH?

BriefCase is an AI-powered communication and collaboration solution designed to streamline the sharing of critical medical imaging findings among care teams. Rapid SDH is an AI module specifically focused on rapidly detecting suspected acute and chronic subdural hematomas on CT scans and delivering notifications in under a minute.

What specific clinical conditions does each tool's AI address?

BriefCase, integrated with the Aidoc platform, supports AI-driven critical finding detection across multiple specialties including Cardiology, Emergency Medicine, Neurology, Pulmonology, and Radiology. Rapid SDH specifically targets the AI-powered detection of suspected hemispheric acute and chronic subdural hematoma (SDH) on non-contrast CT scans.

How do these tools integrate with existing hospital IT infrastructure?

BriefCase offers seamless integration with PACS, RIS, and EHR systems, providing comprehensive audit trails for all communications. Rapid SDH integrates with the Rapid mobile app, PACS, and email for delivering notifications to clinicians.

Are there specific performance metrics available for the AI detection capabilities of each tool?

Rapid SDH provides specific performance metrics, including a high positive predictive value (PPV) of 99%, 93% sensitivity, and 99% specificity for SDHs greater than 1ml. BriefCase's description highlights AI-driven critical finding detection via the Aidoc platform but does not list specific performance metrics for its communication features in the provided information.

How do the mobile capabilities of each tool support clinical workflow?

BriefCase offers mobile access for care team collaboration, enabling secure, real-time communication of findings and automated follow-up tracking. Rapid SDH integrates with the Rapid mobile app to deliver notifications to clinicians in one minute or less, aiding in expedited decision-making and patient care.